The objective of this work was to improve our understanding of the quantitative predictive capabilities of metatranscriptomics. To meet this objective, we investigated whether we can predict the activity level of a specific biochemical function based on the abundance of the corresponding gene transcript within measured community metatranscriptomes. In addition, we investigated the lower limit of a microorganism's abundance that still allows detection of its transcripts within a metatranscriptome and prediction of the activity levels of the enzyme encoded by the transcript. To do this, we amended an undefined microbial community with varying fractions of an Escherichia coli strain that can catalyze a specific transformation reaction for the herbicide atrazine. We observed a linear and proportional relationship between the activity level of the transformation reaction and the abundance of its associated encoding transcript down to an E. coli cell density of 0.05% of the population.
Metagenomics approaches are promising techniques to characterize the genetic content of a variety of microbial communities (Venter et al., 2004; DeLong et al., 2006; Strous et al., 2006; Rusch et al., 2007; Turnbaugh et al., 2009; Qin et al., 2010) . Metagenomic characterizations provide a basis for predicting the functions of a microbial community based on inferences from the types of genes or expressed gene content (messenger RNA) detected within the community. Whereas DNA-based metagenomics attempt to characterize the structure and metabolic potential of the whole community as represented by the community genome (Eisen, 2007) , messenger RNAbased metatranscriptomics provide more precise information on community functions by identifying only expressed gene transcripts, and thereby more accurately reflect the pool of enzymes that are active within the community. Metatranscriptomics is a relatively new technical development, but has recently been applied to characterize functions within a variety of microbial communities (Leininger et al., 2006; Frias-Lopez et al., 2008; Poretsky et al., 2009; Shi et al., 2009; Ettwig et al., 2010; Villa-Costa et al., 2010) .
The predictive capabilities of metatranscriptomics have thus far only been validated qualitatively, where connections have been made between the presence of specific transcripts and observed community functions (García Martín et al., 2006; Ettwig et al., 2010; McCarren et al., 2010) . Questions remain regarding whether metatranscriptomic datasets can also be used to make quantitative predictions on the activity levels of specific functions within microbial communities. The objective of this work was to improve our understanding of the quantitative predictive capabilities of metatranscriptomics by investigating: (i) whether differences in the abundances of specific transcripts within the measured metatranscriptomes of different communities reflect expected differences in the activity levels of their associated encoded enzymes; and (ii) how abundant a microorganism must be within a microbial community to detect its transcripts within a community metatranscriptome and predict the activity levels of its encoded enzymes. We specifically sought to test the case when proportionality is expected between the abundance of a specific transcript and the activity level of its associated encoded enzyme.
To meet this objective, we amended an undefined microbial community derived from a pilot-scale wastewater treatment plant with varying fractions of a recombinant strain of E. coli that constitutively expresses atrazine chlorohydrolase (atzA), an enzyme that transforms the herbicide atrazine (De Souza et al., 1995) . Atrazine chlorohydrolase catalyzes the hydrolysis of atrazine into 2-hydroxy atrazine, a function that was not detected in the community before E. coli addition. Six bioreactors were established in this manner resulting in relative E. coli cell densities that ranged between 0.05 and 100% of the total community cell density. Atrazine was added to each bioreactor at initial concentrations of 0.46 mM (100 mg l À1 ). Samples were taken from each bioreactor over a period of 8 h and were used to measure the activity level of atrazine chlorohydrolase, quantified as the formation rate constant of 2-hydroxy atrazine; a single sample was taken at 4 h to quantify the abundance of the atzA transcript within the community by reverse transcription-quantitative PCR (RT-qPCR) analyses and metatranscriptome sequencing of extracted messenger RNA. Metatranscriptome sequencing was performed using the Illumina Genome Analyzer IIx (Illumina, San Diego, CA, USA) as described in the Supporting Information. RT-qPCR was selected as a complementary tool for this work because, in principle, all atzA transcripts can be amplified and counted during qPCR whereas only a small fraction of the overall sample pool is sequenced by the Illumina platform. Figure 1 displays the results of the measured atrazine chlorohydrolase activities (quantified as the formation rate constant of 2-hydroxy atrazine) and the measured atzA transcript abundances (quantified from the metatranscriptome and by RT-qPCR analysis) for each of the six bioreactors. We observed a linear and proportional relationship between the number of atzA transcripts and the formation rate constant of 2-hydroxy atrazine (hr
À1
) over four orders of magnitude (see the Supplementary Information for statistical analysis of linearity and proportionality). Uncertainty in formation rate constants (shown as vertical error bars in Figure 1 ) was estimated from the 5th and 95th quantiles of parameter density distribution obtained from Markov Chain Monte Carlo sampling as described in the Supporting Information. Even with unquantified uncertainties in the sequence abundances and considering the actual uncertainties in the estimated formation rate constants, non-zero quantitative measurements were still possible for the E. coli function (2-hydroxy atrazine concentrations were above the limit of quantification) and atzA transcripts at the lowest E. coli abundance (0.05% of total community).
As we considered only one specific biological function as a proof of principle, we aimed to generalize our results by considering the catalytic efficiency of the function that was investigated. The catalytic efficiency of an enzyme for a given substrate is expressed with a specificity constant, for example, the ratio of the catalytic constant (k cat ) and the half-saturation (Michaelis) coefficient (K M ). It is plausible that the utility of metatranscriptomics as a predictive tool for community function should be enhanced as catalytic efficiency increases. Enzymes with higher catalytic efficiencies are more likely to have higher activities per unit transcript than enzymes with lower catalytic efficiencies. Consequently, for enzymes with high catalytic efficiencies, the detection of only a few transcripts makes it more likely that the associated enzyme function will also be measurable. The reported catalytic efficiency for the conversion of atrazine by atrazine chlorohydrolase is 7.4 Â 10 4 M À1 s À1 (De Souza et al., 1996) and is among the lowest value of catalytic efficiency for other enzyme-substrate pairs in the literature (Snider et al., 2004) . Thus, our use of the atrazine chlorohydrolase encoded by the atzA transcripts was conservative for this proof of principle. As we could link atzA transcript levels with the activity levels of Figure 1 atzA gene transcripts detected by (m) qPCR and (~) metatranscriptome sequencing versus the rate of 2-hydroxy atrazine formation for each of the six E. coli titration levels (given as percentage of the total cell population). Error bars in the formation rate represent the 90% confidence interval from parameter estimation as described in the Supporting Information. The dashed lines are fit to the data based on model 1 linear regression by minimizing the sum of the squared residual errors and forcing a zero intercept. The coefficients of determination (r 2 ) for the model fits were 0.987 for the qPCR data and 0.970 for the metatranscriptome sequencing data. The inset plots show the data for the reactors with low E. coli cell densities plotted on the same axes (with a reduced scale) as the main plots. atrazine chlorohydrolase (down to 9 atzA transcripts out of 7.3 million total sequence reads), we expect that it is possible to establish links between transcript levels and the activity levels of many other enzymes, even when only a few of these transcripts are detected. The effects of variability in post-transcriptional regulation were not directly investigated in this work, but these effects should not affect the relative abundance of active enzymes compared with transcript abundances. Thus, a proportional relationship between enzyme activity levels and transcript abundance should still be measurable.
In this work, we aimed to improve our understanding of the predictive capabilities of metatranscriptomics. We have shown that for the specific case of atrazine transformation catalyzed by atrazine chlorohydrolase, we could measure the expected proportional relationship between activity levels of atrazine transformation and the abundance of its associated encoding atzA transcript from community metatranscriptomes. Based on literaturereported values of catalytic efficiency, we further conclude that for many well-known enzyme-catalyzed reactions, if a transcript is detected at any level using currently available sequencing technologies then a quantitative prediction about the activity level of its encoded enzyme is plausible when the relationship between transcript abundance and activity is known. Moreover, our results demonstrate that metatranscriptomics approaches are not only useful for predicting the functions of abundant community members, but are also useful for predicting the functions of low-abundance community members that comprise as little as 0.05% of the total cell population. In summary, our results improve our understanding of the quantitative predictive power of metatranscriptomics and are thus relevant in a variety of sectors, including environment, biotechnology, agriculture, and human health and disease.
